A key element of the U.S. Food and Drug Administration’s mission is focused on helping to ensure that all products we regulate, including drugs available...
Continue ReadingGlenmark Pharmaceuticals has announced the appointment of Alessandro Riva as the CEO of its new innovation company.Mr. Riva is currently Executive Vice President, Oncology Therapeutics...
Continue ReadingThe abrupt exit of the US FDA commissioner Scott Gottlieb after a nearly 2-year stint under the Trump administration throws Indian pharma into uncertainty on...
Continue ReadingEven as more blood pressure drugs are being recalled in the USA after being found to contain trace amounts of a potentially cancer-causing ingredient, India’s...
Continue ReadingSuven Life Sciences through its joint venture partner, Shore Suven Pharma, has entered into a ‘stalking-horse’ asset purchase agreement to buy the assets of Aceto...
Continue ReadingThis is the second plant to come out of the warning letter after multiple inspections conducted by the US drug regulator. In a major relief to...
Continue ReadingThe healthcare industry has hailed the Modi government for capping 30 per cent margin on 42 drugs meant for the cancer patients. The industry insiders...
Continue ReadingEven as the Central Drugs Standards Control Organisation (CDSCO) has set the ball rolling for BA/BE (bioavailability/ bioequivalence) submissions, the pharma and biotech industry in...
Continue ReadingSlayback Pharma LLC announced today that it has received final approval for Hydroxyprogesterone Caproate Injection, USP 250 mg/ 1 ml. This is the second ANDA...
Continue Reading